US 10039802
Methods of treating chronic disorders with complement inhibitors
granted A61KA61K31/7088A61K31/7105
Quick answer
US patent 10039802 (Methods of treating chronic disorders with complement inhibitors) held by Apellis Pharmaceuticals, Inc. expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apellis Pharmaceuticals, Inc.
- Grant date
- Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/7088, A61K31/7105, A61K38/10, A61K38/12